J
Joseph D. Khoury
Researcher at University of Texas MD Anderson Cancer Center
Publications - 427
Citations - 9367
Joseph D. Khoury is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Lymphoma. The author has an hindex of 39, co-authored 372 publications receiving 6324 citations. Previous affiliations of Joseph D. Khoury include University of Texas Health Science Center at Houston & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury,Eric Solary,Oussama Abla,Yassmine Akkari,Rita Alaggio,Jane F. Apperley,Rafael Bejar,Emilio Berti,Lambert Busque,John K.C. Chan,Weina Chen,Xi Chen,Wee Joo Chng,John K. Choi,Isabel Colmenero,Sarah E. Coupland,Nicholas C.P. Cross,Daphne de Jong,M. Tarek Elghetany,Emiko Takahashi,Jean-François Emile,Judith A. Ferry,Linda Fogelstrand,Michaela Fontenay,Ulrich Germing,Sumeet Gujral,Torsten Haferlach,Claire N. Harrison,Jennelle C. Hodge,Shimin Hu,Joop H. Jansen,Rashmi Kanagal-Shamanna,Hagop M. Kantarjian,Christian P. Kratz,Xiao-Qiu Li,Megan S. Lim,Keith R. Loeb,Sanam Loghavi,Andrea N. Marcogliese,Soheil Meshinchi,Phillip Michaels,Kikkeri N. Naresh,Yasodha Natkunam,Reza Nejati,German Ott,Eric Padron,Keyur Patel,Nikhil Patkar,Jennifer Picarsic,Uwe Platzbecker,Irene Roberts,Anna Schuh,William C. Sewell,Reiner Siebert,Prashant Tembhare,Jeffrey W. Tyner,Srdan Verstovsek,Wei Wang,Brent L. Wood,W Q Xiao,Cecilia Yeung,Andreas Hochhaus +61 more
TL;DR: The 5th edition of the World Health Organization (WHO) Classification of Haematolymphoid Tumours is part of an effort to hierarchically catalogue human cancers arising in various organ systems within a single relational database as discussed by the authors .
Book ChapterDOI
Mantle Cell Lymphoma
TL;DR: Mantle cell lymphoma (MCL) is a B-cell neoplasm thought to derive from mantle zone B-cells and characterized by translocations involving the CCND1 gene, most commonly t(11,14),q13,q23 as discussed by the authors.
Journal ArticleDOI
Ewing sarcoma family of tumors
TL;DR: The Ewing sarcoma family of tumors (ESFT) comprises morphologically heterogeneous tumors that are characterized by nonrandom chromosomal translocations involving the EWS gene and one of several members of the ETS family of transcription factors.
Journal ArticleDOI
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Nitin Jain,Audrey Lamb,Susan O'Brien,Farhad Ravandi,Marina Konopleva,Elias Jabbour,Zhuang Zuo,Jeffrey L. Jorgensen,Pei Lin,Sherry Pierce,Deborah A. Thomas,Michael Rytting,Gautam Borthakur,Tapan M. Kadia,Jorge E. Cortes,Hagop M. Kantarjian,Joseph D. Khoury +16 more
TL;DR: Novel treatment strategies are needed to improve treatment outcomes in this T-ALL/LBL subset, which represents a high-risk disease subtype of adult ALL.
Journal ArticleDOI
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A single-centre, phase 2 study
Elias J. Jabbour,Hagop M. Kantarjian,Farhad Ravandi,Deborah A. Thomas,Xuelin Huang,Stefan Faderl,Naveen Pemmaraju,Naval Daver,Guillermo Garcia-Manero,Koji Sasaki,Jorge E. Cortes,Rebecca Garris,C. Cameron Yin,Joseph D. Khoury,Jeffrey L. Jorgensen,Zeev Estrov,Zachary S. Bohannan,Marina Konopleva,Tapan M. Kadia,Nitin Jain,Courtney D. DiNardo,William G. Wierda,Vicky Jeanis,Susan O'Brien +23 more
TL;DR: Ponatinib is a more potent BCR-ABL1 inhibitor than all other tyrosine-kinase inhibitors and selectively suppresses the resistant T315I clones as discussed by the authors.